Browse Category

Mergers & Acquisitions News 28 November 2025 - 1 December 2025

Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now

Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now

Exact Sciences Corporation (NASDAQ: EXAS) has turned into one of the most closely watched healthcare stocks heading into December 2025, thanks to a blockbuster takeover agreement with Abbott Laboratories, strong Q3 results, and a rapid share‑price rally that has pushed EXAS to all‑time highs. As of mid‑day on December 1, 2025, the stock trades around $101 per share, just below the agreed $105 per‑share cash buyout price. Exact Sciences Investor Relations+1 Below is a deep dive into the latest news, earnings, analyst forecasts, and key risks around Exact Sciences stock as of December 1, 2025. Exact Sciences Stock Today: Trading
Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook

Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook

On December 1, 2025, Q32 Bio Inc. (NASDAQ: QTTB) suddenly became one of the most-watched small-cap biotech stocks on Wall Street. Shares of Q32 Bio surged intraday by roughly 90%–170% at various points in Monday’s session, with trading volume soaring from a typical few hundred thousand shares to tens or even hundreds of millions, after the company announced a major asset sale to Akebia Therapeutics. TipRanks+224/7 MarketNews+2 At the center of the move: the sale of Q32 Bio’s Phase 2 complement inhibitor ADX-097 to Akebia in a deal worth $12 million in upfront and near-term cash and up to $592
ServiceNow (NOW) Stock on December 1, 2025: Q3 Beat, AI Awards, $1B Veza Deal Talk and What 2026 Price Targets Signal

ServiceNow (NOW) Stock on December 1, 2025: Q3 Beat, AI Awards, $1B Veza Deal Talk and What 2026 Price Targets Signal

Published: December 1, 2025 — informational only, not investment advice. ServiceNow stock today: trading around $820 after a rough autumn As of the latest trade on Monday, December 1, 2025, ServiceNow, Inc. (NYSE: NOW) is changing hands at roughly $820 per share, with intraday quotes around $818–$821. Barchart.com That puts the workflow‑software and AI platform company: Market cap sits around $170 billion, leaving ServiceNow firmly in large‑cap territory even after the pullback. Barchart.com+1 In other words: the business is hitting new highs, but the stock is in a correction, trading below its 50‑day and 200‑day moving averages since late July,
Zeekr Group Stock (NYSE: ZK): Merger Countdown, November Deliveries and 2026 Price Targets

Zeekr Group Stock (NYSE: ZK): Merger Countdown, November Deliveries and 2026 Price Targets

Published: December 1, 2025 Overview: Where Zeekr Group Stock Stands Today Zeekr Group, officially ZEEKR Intelligent Technology Holding Limited (NYSE: ZK), enters December 2025 at a pivotal moment: At the same time, ZK is subject to a $26.87 per ADS cash take‑private offer from Geely, or a share‑swap alternative, which now dominates the stock’s risk‑reward profile. Finviz 1. Latest Zeekr Stock News as of December 1, 2025 1.1 Strong November 2025 Deliveries On December 1, 2025, Zeekr reported November 2025 delivery data via a press release that has been summarized by GuruFocus: GuruFocus The article highlights that Zeekr continues to
American Water Stock (AWK) in December 2025: Merger, Rate Hikes and Dividend Growth – What Investors Need to Know

American Water Stock (AWK) in December 2025: Merger, Rate Hikes and Dividend Growth – What Investors Need to Know

Published December 1, 2025 American Water stock today: defensive utility trading around $130 American Water Works Company, Inc. (NYSE: AWK) – the largest regulated water and wastewater utility in the United States – remains a classic defensive stock built around regulated earnings and steady dividends. The company provides water and wastewater services to more than 14 million people across 14 states and 18 military installations, supported by a workforce of roughly 6,700 professionals. American Water+1 As of the latest session on December 1, 2025, American Water stock is trading around $130 per share, with: StockAnalysis+1 Price performance has been modest. One quantitative service
SolGold Stock Soars After Rejecting Jiangxi Copper’s $1 Billion Bid – What’s Next for SOLG / SLGGF?

SolGold Stock Soars After Rejecting Jiangxi Copper’s $1 Billion Bid – What’s Next for SOLG / SLGGF?

SolGold plc (LON: SOLG, OTC: SLGGF) has just turned into one of the liveliest dramas on the London market. After a year of “transformational” financing and project progress at its Cascabel copper–gold project in Ecuador, the company is now in a formal takeover “offer period” following a rejected approach from China’s Jiangxi Copper – and the share price has ripped higher on both sides of the Atlantic. Investing.com+2London South East+2 This article pulls together the key news, forecasts and analyses up to 1 December 2025, and looks at what all of this might mean for investors watching SolGold’s volatile stock. SolGold in
Spectris Share Price on 1 December 2025: KKR £41.75 Takeover Nears the Finish Line as New Voting and Stake Disclosures Land

Spectris Share Price on 1 December 2025: KKR £41.75 Takeover Nears the Finish Line as New Voting and Stake Disclosures Land

London, 1 December 2025 – Spectris plc (LON: SXS), the precision‑measurement specialist at the centre of one of this year’s biggest UK mid‑cap takeovers, is now deep in “end‑game” territory. The KKR‑backed £41.75‑per‑share cash offer is almost fully de‑risked, fresh regulatory filings are trickling in, and the clock is ticking toward delisting from the London Stock Exchange later this week. Spectris+1 Below is a full run‑through of today’s news, the latest takeover timetable, recent trading performance and what analysts are still saying about Spectris stock. Spectris share price: trading pinned just below the KKR offer In late‑November trading, Spectris shares
Anglo American (AAL) Stock Outlook 2025: Teck Merger, BHP Exit and Copper Boom Reshape the Investment Case

Anglo American (AAL) Stock Outlook 2025: Teck Merger, BHP Exit and Copper Boom Reshape the Investment Case

Anglo American plc (LON:AAL), one of the world’s largest diversified miners, sits at the centre of multiple storylines as of 1 December 2025: a proposed “merger of equals” with Canada’s Teck Resources, the end of BHP’s takeover ambitions, a sweeping portfolio restructuring, and a powerful upswing in copper prices. For investors trying to decide what to do with Anglo American stock now, the picture is complex but unusually clear: this is becoming a copper‑heavy, energy‑transition‑focused miner, with high strategic upside and equally meaningful execution and regulatory risk. Anglo American share price today: where the stock stands As of the latest
Pfizer Stock Price Today (PFE): TrumpRx Drug Deal, $10B Metsera Buyout and 2026 Forecast

Pfizer Stock Price Today (PFE): TrumpRx Drug Deal, $10B Metsera Buyout and 2026 Forecast

Updated November 30, 2025 Pfizer stock is in the middle of a big reset. The COVID windfall is fading, but a massive obesity-drug acquisition, a landmark bladder‑cancer approval and a high dividend yield are reshaping the story investors see in PFE. Pfizer stock price today: valuation snapshot As of the last trading session on Friday, November 28, Pfizer Inc. (NYSE: PFE) closed at $25.74 per share. That gives the company a market capitalization of roughly $146 billion. Investing.com Key current metrics: Pfizer’s share price is still down sharply from its 2021–2022 COVID peak above $50, so even after a modest 2025 rebound, the stock
Omnicom Group (OMC) Stock Before the Bell on December 1, 2025: IPG Mega‑Merger, Dividend Hike and Debt Exchange Put Shares at a Crossroads

Omnicom Group (OMC) Stock Before the Bell on December 1, 2025: IPG Mega‑Merger, Dividend Hike and Debt Exchange Put Shares at a Crossroads

As U.S. markets head into the open on Monday, December 1, 2025, Omnicom Group Inc. (NYSE: OMC) is one of the most event‑packed names in the advertising sector. After a week that saw the Interpublic Group (IPG) mega‑merger close, a multi‑billion‑dollar debt exchange wrap up, and a double‑digit dividend hike, Omnicom stock goes into December priced like a value name but carrying all the execution risk of a newly formed global giant. StockAnalysis+2TS2 Tech+2 Below is a detailed, news‑driven look at where OMC stands before Monday’s open, based on all the major news, forecasts and analyses published between 28–30 November
Hanesbrands (HBI) Stock Outlook Before the December 1, 2025 Open: Russell Index Exit, Gildan Merger and Heavy Trading in Focus

Hanesbrands (HBI) Stock Outlook Before the December 1, 2025 Open: Russell Index Exit, Gildan Merger and Heavy Trading in Focus

As Wall Street heads into the first trading day of December, Hanesbrands Inc. (NYSE: HBI) is sitting at the crossroads of three powerful storylines: removal from major equity indexes, an approved $2.2 billion takeover by Gildan Activewear, and an explosion in trading volume that has turned the stock into a battleground for arbitrage funds and value hunters. TS2 Tech+1 With U.S. markets set to open on Monday, December 1, 2025, investors following Hanesbrands stock before the bell are weighing whether Friday’s selloff, index-driven flows, and the merger spread leave room for upside — or signal more volatility ahead. Where Hanesbrands
Omnicom Group (OMC) Stock on November 30, 2025: Interpublic Mega‑Merger, Dividend Hike and Debt Exchange Put Ad Giant at a Turning Point

Omnicom Group (OMC) Stock on November 30, 2025: Interpublic Mega‑Merger, Dividend Hike and Debt Exchange Put Ad Giant at a Turning Point

Omnicom Group Inc. (NYSE: OMC) heads into the final month of 2025 as a very different company than it was a week ago. The advertising holding group has closed its transformational merger with Interpublic, raised its dividend, wrapped up a multi‑billion‑dollar debt exchange and seen trading volume spike, even as the share price lags far behind analyst targets. MarketBeat+3Omnicom Group+3Stock Titan+3 Here’s a rundown of the latest Omnicom stock news as of November 30, 2025, and what it means for investors watching OMC. OMC stock price today: weak year, big week U.S. markets are closed this weekend, so the latest
Hanesbrands (HBI) Stock on November 30, 2025: Index Removal, Gildan Merger and Heavy Trading – All the Latest News

Hanesbrands (HBI) Stock on November 30, 2025: Index Removal, Gildan Merger and Heavy Trading – All the Latest News

As November 2025 ends, Hanesbrands Inc. (NYSE: HBI) sits at the intersection of three big storylines: removal from major equity indexes, a pending $4.4 billion takeover by Gildan Activewear, and a business that is improving its margins but still struggling for top-line growth. Here’s a full rundown of the most current developments investors need to know as of 30 November 2025. HBI stock snapshot going into December The U.S. markets are closed this Sunday, so the latest data point for Hanesbrands comes from Friday, 28 November 2025: In other words, HBI is still a recovery story off its lows, but
Qualcomm (QCOM) Stock on November 30, 2025: AI Data Centers, Alphawave Deal and Arduino Acquisition Reframe the Story

Qualcomm (QCOM) Stock on November 30, 2025: AI Data Centers, Alphawave Deal and Arduino Acquisition Reframe the Story

As of Sunday, November 30, 2025, Qualcomm Incorporated (NASDAQ: QCOM) heads into December with its stock trading around $168 per share, after a solid post‑Thanksgiving bounce and an eventful month of AI‑heavy announcements and deal progress. The latest close on Friday, November 28, was just under $168 on light volume, valuing the chip designer at roughly $180 billion. stoculator.com+2TradingView+2 Year to date, Qualcomm shares are up only about 6% in 2025, far behind the Nasdaq Composite’s roughly 19% gain, and the stock remains more than 20% below its 52‑week high around $206 and about 27% below its June 2024 all‑time
Palo Alto Networks (PANW) Stock on November 30, 2025: Chronosphere Deal, Quantum-Safe Push and CyberArk Merger Drive a Volatile Repricing

Palo Alto Networks (PANW) Stock on November 30, 2025: Chronosphere Deal, Quantum-Safe Push and CyberArk Merger Drive a Volatile Repricing

As of November 30, 2025, Palo Alto Networks, Inc. (NASDAQ: PANW) heads into December as one of the most closely watched names in cybersecurity, AI infrastructure and now observability. Yet its stock price is still digesting a month packed with earnings, mega-deals and new product announcements. Palo Alto Networks last closed at $190.13 per share on November 28, 2025, up about 2.6% on the day and roughly 3% over the past week, but still around 15–17% below its 52‑week high of $223.61. MacroTrends+1 The company’s market capitalization sits in the low‑$130 billion range, with the stock trading on a rich
Omnicom Group (OMC) Stock Today: IPG Mega‑Merger, Dividend Hike and Debt Deal Shape 2026 Outlook

Omnicom Group (OMC) Stock Today: IPG Mega‑Merger, Dividend Hike and Debt Deal Shape 2026 Outlook

Date: November 29, 2025 Omnicom Group Inc. (NYSE: OMC) is entering one of the most important phases in its history. In the space of a few days, the company has: All of this is happening while Omnicom’s share price trades more than 30% below its 52‑week high, keeping the stock firmly on the radar of value‑oriented investors. StockAnalysis+1 Below is a rundown of the key current news around Omnicom stock as of November 29, 2025, and what it may mean for shareholders ahead of 2026. OMC stock today: trading near the low end of its 52‑week range As of the
Constellation Energy (CEG) Stock: Latest News on DOE Loan, Calpine Deal and AI Power Boom — November 29, 2025

Constellation Energy (CEG) Stock: Latest News on DOE Loan, Calpine Deal and AI Power Boom — November 29, 2025

BALTIMORE — Constellation Energy Corporation (NASDAQ: CEG) remains one of Wall Street’s most-watched utility names as of Saturday, November 29, 2025, with its share price hovering just below record highs and a stack of fresh catalysts: a $1 billion U.S. government loan to restart a nuclear reactor at the former Three Mile Island site, progress toward closing its $26.6 billion acquisition of Calpine, and still-surging demand from AI data centers and electrification. Benzinga+3Reuters+3Reuters+3 On Friday, CEG stock closed at about $364.36, up 1.47% on the day and not far from its 52‑week high of $412.70, giving the company a market
Hanesbrands (HBI) Stock on November 29, 2025: Gildan Merger Vote, Q3 Earnings, and Heavy Trading Pressure

Hanesbrands (HBI) Stock on November 29, 2025: Gildan Merger Vote, Q3 Earnings, and Heavy Trading Pressure

Hanesbrands Inc. (NYSE: HBI) stock is in the spotlight as of November 29, 2025, following a decisive shareholder vote in favor of its merger with Gildan Activewear, a mixed third-quarter earnings season, and an unusually heavy spike in trading volume heading into the weekend. Together, these developments are shaping both the near-term price action and the longer-term outlook for HBI shares. Latest HBI Stock Performance: Weak Session, Huge Volume On Friday, November 28, 2025, Hanesbrands shares fell 1.82% to close at $6.47, marking a second consecutive day of losses and underperforming a broadly positive U.S. equity market. The S&P 500
BP Share Price Today, 28 November 2025: Buybacks, Castrol Deal Talks and Olympic Pipeline News Shape the Outlook

BP Share Price Today, 28 November 2025: Buybacks, Castrol Deal Talks and Olympic Pipeline News Shape the Outlook

BP’s share price edged higher on Friday, 28 November 2025, as investors weighed steady oil prices around $63 a barrel, another sizeable share buyback, ongoing talks over a sale of the Castrol lubricants business, and fresh developments around the Olympic Pipeline leak in the United States. BP share price today on the London Stock Exchange (LON: BP.) BP’s primary listing in London finished the session firmly in positive territory. Different data providers show slightly different last prices (for example, Google Finance shows 453.55p as of 4:52 p.m. UTC), but they all point to a modest rebound after Thursday’s dip and
El Jannah Sold to US Private Equity Giant General Atlantic in Near-$1 Billion Deal, with Plans to Quadruple Stores and Go Global

El Jannah Sold to US Private Equity Giant General Atlantic in Near-$1 Billion Deal, with Plans to Quadruple Stores and Go Global

Sydney, Australia — 28 November 2025 Australia’s cult charcoal chicken chain El Jannah has agreed to a massive private equity deal that values the business at between A$800 million and close to A$1 billion, in one of the most eye‑catching fast‑food transactions the country has seen.The Australian+2Real Commercial+2 New York–based investment firm General Atlantic is taking a major stake in the Western Sydney–born brand, backing an aggressive plan to quadruple El Jannah’s network from about 50 restaurants to nearly 200 and to take the Lebanese‑inspired chicken favourite into new Australian states and, for the first time, overseas – starting with
28 November 2025
1 9 10 11 12 13 20

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop